This set of KAP Keys for clinicians based on Treatment Improvement Protocol 49 provides a series of quick-reference cards with information about each of the four Food and Drug Administration-approved medications for treating alcohol use disorders (acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone) as well as concise information regarding patient management.
Read Full Publication (PDF)